Lavaa Health News
5 articlesThe AI tech that can spot serious illness before the doctor - ISRAEL21c
growth-positive
Promising Results: Lavaa Health Platform Reduces Hospital Admissions by 38% in High-Risk Patients with Multiple Chronic Diseases - Insurtech Israel News
Lavaa Health Platform has released preliminary results indicating that its modules significantly reduce the deterioration of high-risk co-morbid patients by over 38%. This suggests a positive impact on preventing hospital admissions for patients with multiple chronic diseases. Lavaas platform enables providers, clinicians, and payers to create personalized care programs that facilitate early detection of various chronic, oncological, and mental health conditions. The platform integrates with existing electronic health records and clinical systems, offering insights and functions that enhance efficacy, reduce hospitalizations, and allow clinicians to focus more on patient care.
growth-positive
10 Top Healthcare Startups to Watch in 2025 | StartUs Insights
The article highlights the impact of the COVID-19 pandemic on the development of healthcare technologies and introduces 10 healthcare startups to watch in 2025. These startups are innovating in areas such as diagnostics, cold plasma technology, wearables-based monitoring, and medical drone delivery. The report emphasizes the role of digital health technologies, AI-driven diagnostic tools, personalized medicine, and telehealth services in reshaping patient care. It also discusses the challenges of data privacy and regulatory compliance. The startups, including GoodLeven, ZappCare, and Prudent, are transforming the healthcare industry by offering novel solutions that improve patient outcomes, streamline administrative workflows, and enhance medical training.
growth-positive
How Do You Prevent the Next Disease?
LAVAA, a healthcare technology company, is revolutionizing medical diagnostics by using data analysis to predict and prevent illnesses. Co-founded by Adam Amitai and Izhak Lax, LAVAAs platform integrates into existing medical systems to provide early detection and personalized treatment plans. The company has raised $4 million and is expanding its operations into the UK and EU markets. LAVAA is also collaborating with global pharmaceutical and technological companies to enhance its offerings. The companys approach aims to improve healthcare outcomes while reducing costs, benefiting patients, medical teams, insurance, and pharmaceutical companies alike.
InvestmentPartners
growth-positive
איך מונעים את המחלה הבאה?
LAVAA, a company focused on healthcare innovation, has developed a platform that uses AI technology to analyze personal medical data for early detection and prevention of chronic, oncological, and rare diseases. The platform aims to improve long-term health outcomes and reduce unnecessary healthcare costs. LAVAA recently raised $4 million and is conducting pilot programs in Israel and the USA, with plans to expand into the European and UK markets. The company is also forming strategic partnerships with leading pharmaceutical and technology companies worldwide to develop innovative solutions. LAVAAs approach offers a win-win situation for patients, healthcare providers, insurance companies, and pharmaceutical firms by ensuring that only suitable patients receive specific treatments.
InvestmentPartners
